Friday, 24 March 2017 17:22
Cuban Vaccine against Lung Cancer Goes to Clinical Trial at Primary Health Care Level
Havana, Cuba.- With nearly 200 patients, a clinical trial of the drug Cimavax EGF against lung cancer in primary health care (PHC) is being developed in Cuba to evaluate other parameters in order to increase the effectiveness of the first vaccine of its type registered in the world.
Published in
Health
Thursday, 07 April 2016 12:14
Clinical Trials of Promising Cuban Monoclonal Antibody Expanded
Registered in Cuba to treat head, neck, brain (in children and adults), esophageal and more recently, pancreatic tumors, with encouraging life-extending results, the humanized monoclonal antibody nimotuzumab is currently subject to 27 clinical trials to ensure its safety and effectiveness in the treatment of a further 11 types of cancer.
Published in
Health
